The institute is internationally recognized for developing the Creighton Model FertilityCare System and NaPro Technology (natural procreative technology). The Creighton Model tracks biomarkers to monitor hormonal events during a woman’s menstrual cycle to determine fertility. It can be used in conjunction with NaPro Technology to diagnose and treat reproductive and gynecological problems, and employ medical and surgical approaches to correct conditions while sustaining procreative potential.
Wednesday, September 22, 2010
The Denver Catholic Register today published an incisive article by Julie Filby about the Creighton FertilityCare System and the Pope Paul VI Institute.